11 Paul Tudor Jones II Ventyx Biosciences Trades
Paul Tudor Jones II acquired 17.8 Thousand Ventyx Biosciences shares worth $20.8 Thousand. That's 0.00% of their equity portfolio (1371st largest holding). The first Ventyx Biosciences trade was made in Q2 2022. Since then Paul Tudor Jones II bought shares four more times and sold shares on six occasions. The investor's estimated purchase price is $368 Thousand, resulting in a loss of 94%.
Avg closing price
Price range
Sold 12.7% shares (-2.58 Thousand shares)
Q4 2024
Avg closing price
$2.27
Price range
$1.72
-
$3.12
Sold 27.6% shares (-7.78 Thousand shares)
Q3 2024
Avg closing price
$2.30
Price range
$1.85
-
$3.20
Increased shares by 45.4% (+8.79 Thousand shares)
Q2 2024
Avg closing price
$4.15
Price range
$2.31
-
$5.59
Sold 49.9% shares (-19.2 Thousand shares)
Q1 2024
Avg closing price
$4.57
Price range
$1.90
-
$10.13
Increased shares by 546.7% (+32.6 Thousand shares)
Q4 2023
Avg closing price
$9.50
Price range
$2.08
-
$31.18
Sold 79.6% shares (-23.3 Thousand shares)
Q3 2023
Avg closing price
$34.57
Price range
$29.80
-
$40.30
Increased shares by 20.1% (+4.89 Thousand shares)
Q2 2023
Avg closing price
$34.47
Price range
$28.53
-
$39.55
New holding (+24.3 Thousand shares)
Q1 2023
Avg closing price
$38.88
Price range
$29.51
-
$46.65
Sold -22.4 Thousand shares
Q4 2022
Avg closing price
$29.62
Price range
$24.16
-
$36.38
Sold 37.1% shares (-13.2 Thousand shares)
Q3 2022
Avg closing price
$22.14
Price range
$12.64
-
$38.70
New holding (+35.6 Thousand shares)
Q2 2022
Avg closing price
$14.94
Price range
$11.95
-
$18.75
